Senior insider sale
Chief Financial Officer at EDGEWISE THERAPEUTICS, INC. — senior position signals high conviction
$9.41M
367.54K shares
What this filing means
CARRUTHERS R MICHAEL plans to sell 367.54K shares of EDGEWISE THERAPEUTICS, INC. valued at approximately $9.41M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/15/2026ACC: 0001950047-26-000490
Officer· Chief Financial Officer
Since Mar 2021
367.54K
Shares to sell
$9.41M
Approx. market value
180.87K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Exercise of options under a registered plan
Not Applicable
1/15/2026
14.21KExercise of options under a registered plan
Not Applicable
1/15/2026
166.66KTotal acquired180.87K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Exercise of options under a registered plan Not Applicable | 14.21K | — |
1/15/2026 | Exercise of options under a registered plan Not Applicable | 166.66K | — |
| Total | 180.87K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
116.67K
Market value
$3.04M
12/29/2025
—Completed
Units to sell
70K
Market value
$1.57M
11/17/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
180.87K
Market value
$4.80M
1/15/2026
Total
Units
367.54K
Value
$9.41M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/29/2025 | 116.67K | $3.04M | — | Completed |
11/17/2025 | 70K | $1.57M | — | Completed |
| Planned — Approximate Date | ||||
1/15/2026 | 180.87K | $4.80M | NASDAQ | Planned |
| Total | 367.54K | $9.41M | ||